CRO support for drug substance development and manufacture

Ended Awarded Last action

Contract number
HHSN271201700005I
Awardee
Awarding agency
Task orders
4 $6,668,491 obligated

Award facts

Opportunity
Combined order value
  • $6,668,491 Current, with exercised options
  • $7,332,870 Potential, with all options
Last date to order 100% complete
IDV ceiling 27% used
$24,598,861.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Chemistry, manufacturing, and controls (CMC) development of NCGC00413972 for preclinical safety evaluation and clinical… 75N95023F00001 National Institute on Drug Abuse (NIH) $907,792
CMC development of (r)-VK4-116 dihydrochloride salt 75N95020F00002 National Institute on Drug Abuse (NIH) $1,795,195
Production of non-GMP batches of paynantheine, speciogynine, and speciociliatine salts 75N95020F00001 National Institute on Drug Abuse (NIH) $1,174,494
Manufacture of 5.5-KG cgmp mitragynine 75N95019F00088 National Institute on Drug Abuse (NIH) $2,791,010

Transactions

Action Obligated Date
Vendor DUNS or Name Change - Non-Novation P00005 $0
Vendor DUNS or Name Change - Non-Novation P00004 · Parent IDIQ award: CRO support for ncats drug substance development and manufacture $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 -$5,000
Other Administrative Action 1 $0
Original award $5,000

Quick answers

Who was awarded contract HHSN271201700005I?

HHSN271201700005I was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 30, 2017.

How much is contract HHSN271201700005I worth?

Orders under HHSN271201700005I have obligated $6,668,491. Their combined potential value, with all options, is $7,332,870. HHSN271201700005I's own ceiling is $24,598,861.

How many orders have been placed under contract HHSN271201700005I?

4 orders have been placed under HHSN271201700005I, the latest on September 30, 2023.

Which agency awarded contract HHSN271201700005I?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201700005I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract HHSN271201700005I?

HHSN271201700005I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201700005I part of a contract vehicle?

Yes. HHSN271201700005I is part of CRO Support for NCATS Drug Substance Development and Manufacture.

Was contract HHSN271201700005I competed?

The extent of competition for HHSN271201700005I was full and open competition. The government received 10 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login